Skip to main content
. 2012 Jul 10;7(7):e38995. doi: 10.1371/journal.pone.0038995

Figure 3. Effects of the MWCNTs on the platelets viability.

Figure 3

(a) Flow cytometric analysis plots of the anticoagulant blood exposed with the MWCNTs at 0.16 mg/ml. The red dots represent viable platelets that express CD61. (b) Percentage of the CD61+ platelets in the blood. *: significantly different from the negative control (*p<0.05, **p<0.01). Values represent mean ± SD.